Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Preclinical Imaging Market Definition
1.3 Preclinical Imaging Market Scope
1.3.1 Markets Covered
1.3.1.1 Preclinical Imaging Market Segmentation
1.3.1.2 Preclinical Imaging Systems Market Segmentation
1.3.1.3 Preclinical Imaging Reagents Market Segmentation
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Preclinical Imaging Market Size Estimation
2.2.1.1 Bottom-Up Approach
2.2.1.2 Top-Down Approach
2.3 Preclinical Imaging Market Breakdown and Data Triangulation
2.4 Research Assumptions & Limitations
2.4.1 Assumptions
3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights
4.1 Global Preclinical Imaging Market Overview
4.2 Preclinical Imaging Products Market Share, By Region (2016)
4.3 Global Preclinical Imaging Systems Market, By Modality (2016–2021)
4.4 Global Preclinical Imaging Reagents Market, By Type (2016–2021)
4.5 Preclinical Imaging Market, By Region (2016 vs 2021)
5 Preclinical Imaging Market Overview
5.1 Introduction
5.2 Preclinical Imaging Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Technological Advancements in the Field of Molecular Imaging
5.2.1.2 Increasing Market Demand for Noninvasive Small-Animal Imaging Techniques
5.2.1.3 Growing Number of Public-Private Initiatives and Funding to Support Preclinical Researches
5.2.2 Key Market Restraints
5.2.2.1 Strict Regulations Governing Preclinical Research
5.2.2.2 Significant Installation and Operational Costs Associated With Preclinical Imaging Modalities
5.2.3 Key Market Opportunity
5.2.3.1 Emerging Markets to Offer New Growth Opportunities
5.2.4 Key Market Challenge
5.2.4.1 Technological and Procedural Limitations Associated With Standalone Preclinical Imaging Systems
6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.3.1 Key Stakeholders
6.3.2 Key Influencers
6.4 Industry Trends
6.4.1 Ongoing Development of Hybrid and Multi-Modality Preclinical Imaging Systems
6.5 Porter’s Five Forces Analysis
6.5.1 Threat of New Entrants
6.5.2 Threat of Substitutes
6.5.3 Bargaining Power of Suppliers
6.5.4 Bargaining Power of Buyers
6.5.5 Intensity of Competitive Rivalry
7 Global Preclinical Imaging Market, By Modality
7.1 Introduction
7.2 Optical Imaging Systems
7.2.1 Bioluminescence/Fluorescence Imaging Systems
7.2.2 Standalone Fluorescence Imaging Systems
7.2.3 (Optical + X-Ray)/(Optical + CT) Systems
7.3 Nuclear Imaging Systems
7.3.1 Micro-PET Systems
7.3.1.1 Standalone PET Systems
7.3.1.2 PET/CT Systems
7.3.1.3 PET/MRI Systems
7.3.2 Micro-Spect Systems
7.3.2.1 Standalone Spect Systems
7.3.2.2 Spect/CT Systems
7.3.2.3 Spect/MRI Systems
7.3.3 Trimodality (Spect/PET/CT) Systems
7.4 Micro-MRI
7.5 Micro-Ultrasound
7.6 Micro-CT
7.7 Photoacoustic Imaging Systems
7.8 Magnetic Particle Imaging (MPI) Systems
8 Global Preclinical Imaging Market, By Reagent
8.1 Introduction
8.2 Preclinical Optical Imaging Reagents
8.2.1 Bioluminescent Imaging Reagents
8.2.1.1 Luciferins
8.2.1.2 Proluciferins
8.2.1.3 Coelenterazine
8.2.1.4 Other Bioluminescent Imaging Reagents
8.2.2 Fluorescent Imaging Reagents
8.2.2.1 Green Fluorescent Proteins
8.2.2.2 Red Fluorescent Proteins
8.2.2.3 Infrared Dyes
8.2.2.4 Other Fluorescent Imaging Reagents
8.3 Preclinical Nuclear Imaging Reagents
8.3.1 Preclinical PET Tracers
8.3.1.1 Fluorine-18-Based Preclinical PET Tracers
8.3.1.2 Carbon-11-Based Preclinical PET Tracers
8.3.1.3 Copper-64-Based Preclinical PET Tracers
8.3.1.4 Other PET Tracers
8.3.2 Preclinical Spect Probes
8.3.2.1 Technetium-99m-Based Preclinical Spect Probes
8.3.2.2 Iodine-131-Based Preclinical Spect Probes
8.3.2.3 Gallium-67-Based Preclinical Spect Probes
8.3.2.4 Thallium-201-Based Preclinical Spect Probes
8.3.2.5 Other Spect Probes
8.4 Preclinical MRI Contrast Agents
8.4.1 Gadolinium-Based Preclinical Contrast Agents
8.4.2 Iron-Based Preclinical Contrast Agents
8.4.3 Manganese-Based Preclinical Contrast Agents
8.5 Preclinical Ultrasound Contrast Agents
8.6 Preclinical CT Contrast Agents
8.6.1 Iodine-Based Preclinical CT Contrast Agents
8.6.2 Barium-Based Preclinical CT Contrast Agents
8.6.3 Gold Nanoparticles
8.6.4 Gastrografin-Based Preclinical CT Contrast Agents
9 Preclinical Imaging Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.1 Overview
10.2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
10.3 Competitive Scenario
10.3.1 New Product Launches
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Geographical Expansions
10.3.4 Acquisitions
11 Company Profiles
11.1 Introduction
11.1.1 Geographic Benchmarking
11.2 Perkinelmer, Inc.
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments (2013-2016)
11.2.4 MnM View
11.3 Bruker Corporation
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments (2013-2016)
11.3.4 MnM View
11.4 Fujifilm Holdings Corporation
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments (2013-2016)
11.4.4 MnM View
11.5 Mediso Ltd.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments (2013-2016)
11.6 Milabs B.V.
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments (2013-2016)
11.7 MR Solutions Ltd.
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments (2013-2016)
11.8 Aspect Imaging Ltd.
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments (2013-2016)
11.9 Li-Cor Biosciences
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments (2013-2016)
11.10 Trifoil Imaging
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments (2013-2016)
11.11 Miltenyi Biotec GmbH
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments (2013-2016)
12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
List of Tables
Table 1 Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 2 Global Optical Imaging Systems Market Size, By Type, 2014–2021 (USD Million)
Table 3 Optical Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 4 Bioluminescence/Fluorescence Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 5 Standalone Fluorescence Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 6 Optical + X-Ray/Optical + CT Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 7 Global Nuclear Imaging Systems Market Size, By Type, 2014–2021 (USD Million)
Table 8 Nuclear Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global Micro-PET Systems Market Size, By Type, 2014–2021 (USD Million)
Table 10 Micro-PET Systems Market Size, By Region, 2014–2021 (USD Million)
Table 11 Standalone PET Systems Market Size, By Region, 2014–2021 (USD Million)
Table 12 PET/CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 13 PET/MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 14 Global Micro-Spect Systems Market Size, By Type, 2014–2021 (USD Million)
Table 15 Micro-Spect Systems Market Size, By Region, 2014–2021 (USD Million)
Table 16 Standalone Spect Systems Market Size, By Region, 2014–2021 (USD Million)
Table 17 Spect/CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 18 Spect/MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 19 Trimodality Systems Market Size, By Region, 2014–2021 (USD Million)
Table 20 Micro-MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 21 Micro-Ultrasound Systems Market Size, By Region, 2014–2021 (USD Million)
Table 22 Micro-CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 23 Photoacoustic Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 24 Magnetic Particle Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 25 Global Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 26 Global Preclinical Optical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 27 Preclinical Optical Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 28 Global Preclinical Bioluminescent Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 29 Preclinical Bioluminescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 30 Preclinical Luciferins Market Size, By Region, 2014–2021 (USD Million)
Table 31 Preclinical Proluciferins Market Size, By Region, 2014–2021 (USD Million)
Table 32 Preclinical Coelenterazine Market Size, By Region, 2014–2021 (USD Million)
Table 33 Other Preclinical Bioluminescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 34 Global Preclinical Fluorescent Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 35 Preclinical Fluorescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 36 Preclinical Green Fluorescent Proteins Market Size, By Region, 2014–2021 (USD Million)
Table 37 Preclinical Red Fluorescent Proteins Market Size, By Region, 2014–2021 (USD Million)
Table 38 Preclinical Infrared Dyes Market Size, By Region, 2014–2021 (USD Million)
Table 39 Other Preclinical Fluorescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 40 Global Preclinical Nuclear Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 41 Preclinical Nuclear Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 42 Global Preclinical PET Tracers Market Size, By Type, 2014–2021 (USD Million)
Table 43 Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 44 Fluorine-18-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 45 Carbon-11-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 46 Copper-64-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 47 Other Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 48 Global Preclinical Spect Probes Market Size, By Type, 2014–2021 (USD Million)
Table 49 Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 50 Technetium-99m-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 51 Iodine-131-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 52 Gallium-67-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 53 Thallium-201-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 54 Other Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 55 Global Preclinical MRI Contrast Agents Market Size, By Type, 2014–2021 (USD Million)
Table 56 Preclinical MRI Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 57 Gadolinium-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 58 Iron-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 59 Manganese-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 60 Preclinical Ultrasound Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 61 Global Preclinical CT Contrast Agents Market Size, By Type, 2014–2021 (USD Million)
Table 62 Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 63 Iodine-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 64 Barium-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 65 Gold Nanoparticles Market Size, By Region, 2014–2021 (USD Million)
Table 66 Gastrografin-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 67 Global Preclinical Imaging Systems and Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 68 North America: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 69 North America: Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 70 North America: Preclinical Imaging Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 71 Europe: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 72 Europe: Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 73 Europe: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 74 Asia-Pacific: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 75 Asia-Pacific: Preclinical Imaging Systems Market Size, By Modality, 2014-2021 (USD Million)
Table 76 Asia-Pacific: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoW: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 78 RoW: Preclinical Imaging Systems Market Size, By Modality, 2014-2021 (USD Million)
Table 79 RoW: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 80 Top New Product Launches, 2013–2016
Table 81 Top Agreements, Partnerships, and Collaborations, 2013–2016
Table 82 Top Geographical Expansions, 2013–2016
Table 83 Top Acquisitions, 2013–2016
List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Pre-clinical Imaging Systems Market: Bottom-Up Approach
Figure 4 Pre-clinical Imaging Systems Market: Top-Down Approach
Figure 5 Pre-clinical Imaging Reagents Market: Top-Down Approach
Figure 6 Preclinical Imaging Market: Data Triangulation
Figure 7 Global Preclinical Imaging Systems Market, By Modality, 2016 vs 2021 (USD Million)
Figure 8 Global Preclinical Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Preclinical Imaging Market, By Region, 2016 (USD Million)
Figure 10 Technological Advancements in Molecular Imaging and Increasing Demand for Noninvasive Techniques—Key Market Drivers
Figure 11 North America is Expected to Dominate the Preclinical Imaging Market in 2016
Figure 12 Optical Imaging, Nuclear Imaging, and Micro-MRI Systems to Dominate the Preclinical Imaging Systems Market Till 2021
Figure 13 Optical Imaging and Nuclear Imaging Reagents to Dominate the Preclinical Imaging Reagents Market Till 2021
Figure 14 North America to Command the Largest Share of the Preclinical Imaging Market in 2016
Figure 15 Technological Advancements & Emerging Application Segments to Drive the Growth of the Preclinical Imaging Market Till 2021
Figure 16 Healthcare Expenditure Across Major Countries, 2000–2013
Figure 17 Majority of Product Value of Preclinical Imaging Systems is Added During the Manufacturing and Assembly Phase
Figure 18 Market Players Prefer Both Direct & Indirect Distribution Strategies
Figure 19 Porter’s Five Forces Analysis: Preclinical Imaging Market (2015)
Figure 20 Optical Imaging Systems to Dominate Preclinical Imaging Systems Market Till 2021
Figure 21 Optical Imaging Systems Market, By Type
Figure 22 Nuclear Imaging Systems Market, By Type
Figure 23 Preclinical Imaging Reagents Market, By Type
Figure 24 Preclinical Optical Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 25 Preclinical Nuclear Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 26 Preclinical MRI Contrast Agents Market, By Type, 2016 vs 2021 (USD Million)
Figure 27 Preclinical CT Contrast Agents Market, By Type, 2016 vs 2021 (USD Million)
Figure 28 Asia-Pacific to Be the Fastest-Growing Region in Global Preclinical Imaging Market Till 2021
Figure 29 North America: Preclinical Imaging Market Snapshot
Figure 30 Europe: Preclinical Imaging Market Snapshot
Figure 31 Asia-Pacific: Preclinical Imaging Market Snapshot (2016-2021)
Figure 32 RoW: Preclinical Imaging Market Snapshot (2016-2021)
Figure 33 New Product Launches: Key Growth Strategy Adopted By Majority of Market Players (2013-2016)
Figure 34 Global Preclinical Imaging Market Share, By Key Player (2015)
Figure 35 Increasing Number of New Products Launched is Stimulating the Preclinical Imaging Market Growth
Figure 36 Geographic Revenue Mix of the Top 3 Market Players (2015)
Figure 37 Perkinelmer, Inc.: Company Snapshot
Figure 38 Bruker Corporation: Company Snapshot
Figure 39 Fujifilm Holdings Corporation: Company Snapshot
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs